BrainVectis

The Huntington's disease research field is littered with failures but Bayer AG is hoping that a gene therapy developed at one of its subsidiaries will provide a significant advance in tackling the r

Pharma and biotech drug developers have been targeting disorders affecting the central nervous system for decades but many conditions still have no effective treatments that target the root cause of d